REFERENCES
- Casartelli A., Bonato M., Cristofori P., Crivellente F., Dal Negro G., Masotto I., Mutinelli C., Valko K., Bonfante V. A cell-based approach for the early assessment of phospholipidogenic potential in pharmaceutical research and drug development. Cell Biol. Toxicol. 2003; 19: 161–176, [INFOTRIEVE], [CSA]
- De Broe M. E., Paulus G. J., Verpooten G. A., Roels F., Buyssens N., Wedeen R., Tulkens P. Early effects of gentamicin, tobramycin and amikacin on the human kidney. Kidney Int. 1984; 25: 643–652, [INFOTRIEVE], [CSA]
- Dokko R. C., Cho B. H., Chung B. H. Cellular uptake of stearic, oleic, linoleic, and linolenic acids and their effects on synthesis and secretion of lipids in Hep-G2 cells. Int. J. Biochem. Cell. Biol. 1998; 30: 65–76, [INFOTRIEVE], [CROSSREF], [CSA]
- Drenckhahn D., Jacobi B., Lullmann-Rauch R. Corneal lipidosis in rats treated with amphiphilic cationic drugs. Arzneimittelforschung 1983; 33: 827–831, [INFOTRIEVE], [CSA]
- Elliget K. A., Kolaja G. J. Preparation of primary cultures of rat hepatocytes suitable for in vitro toxicity testing. J. Tissue Culture Methods 1983; 8: 1–6, [CROSSREF], [CSA]
- Feldman S., Wang M.-Y., Kaloyanides G. J. Aminoglycosides induce a phospholipidosis in renal cortex of the rat: an early manifestation of nephrotoxicity. J. Pharmacol. Exp. Ther. 1982; 220: 514–520, [INFOTRIEVE], [CSA]
- Finbloom D. S., Silver K., Newsome D. A., Gunkel R. Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity. J. Rheumatol. 1985; 12: 692–694, [INFOTRIEVE], [CSA]
- Gonzalez-Rothi R. J., Zander D. S., Ros P. R. Fluoxetine hydrochloride (Prozac)-induced pulmonary disease. Chest 1995; 107: 1763–1765, [INFOTRIEVE], [CSA]
- Gum R. J., Hickman D., Fagerland J. A., Heindel M. A., Gagne G. D., Schmidt J. M., Michaelides M. R., Davidsen S. K., Ulrich R. G. Analysis of two matrix metalloproteinase inhibitors and their metabolites for induction of phospholipidosis in rat and human hepatocytes. Biochem. Pharmacol. 2001; 62: 1661–1673, [INFOTRIEVE], [CROSSREF], [CSA]
- Hallberg A., Naeser P., Andersson A. Effects of long-term chloroquine exposure on the phospholipids metabolism in retina and pigment epithelium of the mouse. Acta Ophthalmol 1990; 68: 125–130, [CSA]
- Horn J. W., Jensen C. B., White S. L., Laska D. A., Novilla M. N., Giera D. D., Hoover D. M. In vitro and in vivo ultrastructural changes induced by macrolide antibiotic LY281389. Fundam. Appl. Toxicol. 1996; 32: 205–216, [INFOTRIEVE], [CROSSREF], [CSA]
- Hostetler K. Y., Matsuzawa Y. Studies on the mechanism of drug-induced lipidosis. Cationic amphiphilic drug inhibition of lysosomal phospholipases A and C. Biochem. Pharmacol. 1981; 30: 1121–1126, [INFOTRIEVE], [CROSSREF], [CSA]
- Hruban Z. Pulmonary and generalized lysosomal storage induced by amphiphilic drugs. Environ. Health Perspect. 1984; 55: 53–76, [INFOTRIEVE], [CSA]
- Joshi U. M., Rao P., Kodavanti S., Coudert B., Dwyer T. M., Mehendale H. M. Types of interaction of amphiphilic drugs with phospholipid vesicles. J. Pharmacol. Exp. Ther. 1988; 246: 150–157, [INFOTRIEVE], [CSA]
- Kacew S. Gentamicin or chlorphentermine induction of phospholipidosis in the developing organism: role of tissue and species in manifestation of toxicity. J. Pharmacol. Exp. Ther. 1985; 232: 239–243, [INFOTRIEVE], [CSA]
- Kaloyanides G. J., Pastoriza-Munoz E. Aminoglycoside nephrotoxicity. Kidney Int. 1980; 18: 571–582, [INFOTRIEVE], [CSA]
- Kodavanti U. P., Lockard V. G., Mehendale H. M. In vivo toxicity and pulmonary effects of promazine and chlorpromazine in rats. J. Biochem. Toxicol. 1990; 5: 245–251, [INFOTRIEVE], [CROSSREF], [CSA]
- Kubo M., Gardner M. F., Hostetler K. Y. Binding of propranolol and gentamicin to small unilamellar phospholipids vesicles. Contribution of ionic and hydrophobic forces. Biochem. Pharmacol. 1986; 35: 3761–3765, [INFOTRIEVE], [CROSSREF], [CSA]
- Kubo M., Hostetler K. Y. Metabolic basis of diethylaminoethoxyhexestrol-induced phospholipid fatty liver. Am. J. Physiol. 1987; 252: E375–E379, [INFOTRIEVE], [CSA]
- Lullmann H., Lullmann-Rauch R., Wassermann O. Lipidosis induced by amphiphilic cationic drugs. Biochem. Pharmacol. 1978; 27: 1103–1108, [INFOTRIEVE], [CROSSREF], [CSA]
- Matsuzawa Y., Hostetler K. Y. Studies on drug-induced lipidosis: subcellular locatlization of phospholipids and cholesterol in the liver of rat treated with chloroquine or 4’,4’-bis (diethylaminoethoxy)-α, β-diethyldiphenylethane. J. Lipid Res. 1980; 21: 202–214, [INFOTRIEVE], [CSA]
- Montenez J.-P., Van Bambeke F., Piret J., Brasseur R., Tulkens P. M., Mingeot-Leclercq M.-P. Interactions of macrolide antibiotics (erythromycin A, roxithromycin, erythromycylamine [dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models. Toxicol. Appl. Pharmacol. 1999; 156: 129–140, [INFOTRIEVE], [CROSSREF], [CSA]
- Oikawa H., Maesawa C., Sato R., Oikawa K., Yamada H., Oriso S., Ono S., Yashima-Abo A., Kotani K., Suzuki K., Masuda T. Liver cirrhosis induced by long-term administration of a daily low dose of amiodarone: a case report. World J. Gastroenterol. 2005; 11: 5394–5397, [INFOTRIEVE], [CSA]
- Pessayre D., Bichara M., Degott C., Potet F., Benhamou J. P., Feldmann G. Perhexiline maleate-induced cirrhosis. Gastroenterology 1979; 76: 170–177, [INFOTRIEVE], [CSA]
- Reasor M. J., Kacew S. An evaluation of possible mechanisms underlying amiodarone-induced pulmonary toxicity. Proc. Soc. Exp. Biol. Med. 1996; 212: 297–304, [INFOTRIEVE], [CSA]
- Ruben Z., Anderson S. N., Rorig K. J., Hribar J. D., Bible R. H. Jr. The pH dependence of disobutamide-induced clear cytoplasmic vacuoles in cultured cells. Proc. Soc. Exp. Biol. Med. 1985; 180: 84–91, [INFOTRIEVE], [CSA]
- Ruben Z., Doss D. C., Rorig K. J., Anderson S. N. Disobutamide: a model agent for investigating intracellular drug storage. Toxicol. Appl. Pharmacol. 1989; 97: 57–71, [INFOTRIEVE], [CROSSREF], [CSA]
- Sawada H., Takami K., Asahi S. A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system. Tox. Sci. 2005; 83: 282–292, [CROSSREF], [CSA]
- Seglen P. O. Preparation of isolated rat liver cells. Meth. Cell Biol. 1976; 13: 29–83, [CSA]
- Tashiro Y., Watanabe Y., Enomoto Y. Experimental phospholipidosis induced by 4’,4’-diethyl-aminoethoxyhexestrol. Morphological and biochemical interpretations. Acta Pathol. Jpn. 1983; 33: 929–942, [INFOTRIEVE], [CSA]
- Ulrich R. G., Kilgore K. S., Sun E. L., Cramer C. T., Ginsburg L. C. An in vitro fluorescence assay for the detection of drug-induced cytoplasmic lamellar bodies. Tox. Methods. 1991; 1: 89–105, [CSA]
- Vonderfecht S. L., Stone M. L., Eversole R. R., Yancey M. F., Schuette M. R, Duncan B. A., Ware J. A. Myopathy related to administration of a cationic amphiphilic drug and the use of multidose drug distribution analysis to predict its occurrence. Tox. Pathol. 2004; 32: 318–325, [CROSSREF], [CSA]
- Xia A., Ying F., Hansson A. L., Karlsson H., Xie Y., Bergstrand A., DePierre J. W., Nässberger L. Antidepressant-induced lipidosis with special reference to tricyclic compounds. Prog. Neurobiol. 2000; 60: 501–512, [INFOTRIEVE], [CROSSREF], [CSA]